Anti-4-1BB & TPBG/5t4 Bispecific Antibody (BCRXX749) is a research-grade recombinant antibody targeting CD137. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.